Q3 2020 Holdings
Filed 2020-11-16 | 120 holdings | $7.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $3.8B | 13,301,597 | 52.2% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $1.7B | 41,904,586 | 23.7% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $577.4M | 7,589,294 | 7.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $546.3M | 3,540,270 | 7.5% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $267.7M | 1,019,557 | 3.7% |
| Cerus Corporation(CERS) | COM | 157085101 | $85.8M | 13,713,195 | 1.2% |
| Axsome Therapeutics, Inc.(AXSM) | COM | 05464T104 | $68.4M | 959,757 | 0.9% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $50.5M | 6,330,354 | 0.7% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $43.6M | 12,695,818 | 0.6% |
| Altimmune, Inc.(ALT) | COM | 02155H200 | $29.1M | 2,206,955 | 0.4% |
| Aurinia Pharmaceuticals Inc.(AUPH) | COM | 05156V102 | $23.8M | 1,618,029 | 0.3% |
| Adaptive Biotechnologies Corporation(ADPT) | COM | 00650F109 | $21.4M | 440,539 | 0.3% |
| Seagen Inc.(SGENUSD) | COM | 81181C104 | $9.3M | 47,269,424 | 0.1% |
| Cabaletta Bio, Inc.(CABA) | COM | 12674W109 | $6.9M | 636,363 | 0.1% |
| Autolus Therapeutics plc(AUTL) | SPONSORED ADS | 05280R100 | $5.4M | 461,324 | 0.1% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $4.7M | 302,320 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.9M | 31,999,398 | 0.0% |
| Alector, Inc.(ALEC) | COM | 014442107 | $2.8M | 265,600 | 0.0% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $2.0M | 115,425 | 0.0% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $1.4M | 474,400 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.0M | 8,760,794 | 0.0% |
| Kodiak Sciences Inc.(KOD) | COM | 50015M109 | $731.4K | 12,352,175 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $513.7K | 11,850,962 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $410.3K | 3,009,344 | 0.0% |
| Prelude Therapeutics Incorporated(PRLD) | COM | 74065P101 | $304.9K | 10,118,636 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $234.1K | 1,409,784 | 0.0% |
| IGM Biosciences, Inc.(1K0) | COM | 449585108 | $232.1K | 3,144,446 | 0.0% |
| Exact Sciences Corporation(EXAS) | COM | 30063P105 | $188.2K | 1,846,139 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $178.0K | 1,499,213 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR | 023111206 | $134.8K | 32,018,867 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $88.8K | 5,994,704 | 0.0% |
| Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | $88.3K | 1,771,509 | 0.0% |
| Zymeworks Inc. | COM | 98985W102 | $79.6K | 1,708,472 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $73.0K | 2,272,712 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $65.1K | 676,975 | 0.0% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $63.3K | 1,959,211 | 0.0% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $62.5K | 1,788,921 | 0.0% |
| Allakos Inc.(ALLKGUSD) | COM | 01671P100 | $56.9K | 698,469 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $55.7K | 1,687,500 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $53.6K | 2,471,155 | 0.0% |
| Horizon Therapeutics Public Ltd Co | SHS | G46188101 | $51.8K | 666,500 | 0.0% |
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $50.7K | 920,375 | 0.0% |
| Atreca, Inc.(BCELUSD) | CL A COM | 04965G109 | $49.4K | 3,532,760 | 0.0% |
| ChemoCentryx, Inc.(CCXIEUR) | COM | 16383L106 | $49.3K | 899,821 | 0.0% |
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $45.9K | 3,821,740 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $42.9K | 2,799,577 | 0.0% |
| Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | $42.3K | $30,770,000 | 0.0% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $33.4K | 775,192 | 0.0% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $32.1K | 3,250,000 | 0.0% |
| Protagonist Therapeutics, Inc.(PTGX) | COM | 74366E102 | $31.2K | 1,596,198 | 0.0% |